Bafna Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled to be held on February 04, 2017, to consider among others, the Unaudited Financial Results for the quarter ended December 31, 2016.
The above information is a part of company’s filings submitted to BSE.